High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study.

Saved in:
Bibliographic Details
Title: High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study.
Authors: Zayac AS; Division of Hematology/Oncology, The Warren Alpert Medical School Medical School of Brown University, Providence, RI., Landsburg DJ; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Hughes ME; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Bock AM; Division of Hematology, Mayo Clinic, Rochester, MN., Nowakowski GS; Division of Hematology, Mayo Clinic, Rochester, MN., Ayers EC; Division of Hematology/Oncology, University of Virginia, Charlottesville, VA., Girton M; Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA., Hu M; Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN., Beckman AK; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN., Li S; Division of Pathology and Laboratory Medicine, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Medeiros LJ; Division of Pathology and Laboratory Medicine, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Chang JE; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI., Stepanovic A; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI., Kurt H; Department of Pathology and Laboratory Medicine, The Warren Alpert Medical School of Brown University, Providence, RI., Sandoval-Sus J; Department of Malignant Hematology and Cellular Therapy, Moffitt Cancer Center at Memorial Healthcare System, Pembroke Pines, FL., Ansari-Lari MA; Department of Pathology, Memorial Healthcare System, Hollywood, FL., Kothari SK; Division of Hematology, Yale University School of Medicine, New Haven, CT., Kress A; Division of Hematology, Yale University School of Medicine, New Haven, CT., Xu ML; Department of Pathology and Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT., Torka P; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY., Sundaram S; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY., Smith SD; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.; Division of Medical Oncology, University of Washington, Seattle, WA., Naresh KN; Department of Pathology, University of Washington, Seattle, WA., Karimi YH; Division of Hematology-Oncology, University of Michigan Health, Ann Arbor, MI., Epperla N; The Ohio State University Comprehensive Cancer Center, Columbus, OH., Bond DA; The Ohio State University Comprehensive Cancer Center, Columbus, OH., Farooq U; Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA., Saad M; Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA., Evens AM; Department of Medicine, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ., Pandya K; Department of Medicine, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ., Naik SG; Penn State Cancer Institute, Penn State Hershey Medical Center, Hershey, PA., Kamdar M; Division of Hematology, Hematologic Malignancies and Stem Cell Transplantation, University of Colorado, Denver, CO., Haverkos B; Division of Hematology, Hematologic Malignancies and Stem Cell Transplantation, University of Colorado, Denver, CO., Karmali R; Division of Hematology and Oncology, Northwestern University, Chicago, IL., Oh TS; Division of Hematology and Oncology, Northwestern University, Chicago, IL., Vose JM; Department of Medicine, University of Nebraska Medical Center, Omaha, NE., Nutsch H; Department of Medicine, University of Nebraska Medical Center, Omaha, NE., Rubinstein PG; Department of Medicine, Section of Hematology-Oncology, University of Illinois, Chicago, IL., Chaudhry A; Department of Medicine, Section of Hematology-Oncology, University of Illinois, Chicago, IL., Olszewski AJ; Division of Hematology/Oncology, The Warren Alpert Medical School Medical School of Brown University, Providence, RI.
Source: Blood advances [Blood Adv] 2023 Nov 14; Vol. 7 (21), pp. 6381-6394.
Publication Type: Multicenter Study; Journal Article
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2473-9537
DOI:10.1182/bloodadvances.2023009731